| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/20/2009 | CA2597972A1 Method and composition for treating diabetes |
| 02/19/2009 | WO2009023664A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | WO2009023566A2 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | WO2009023416A2 Cosmetic methods and compositions for repairing human skin |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022009A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 02/19/2009 | WO2009022008A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 02/19/2009 | WO2009022007A1 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative |
| 02/19/2009 | WO2009021824A1 Lactobacillus rhamnosus and weight control |
| 02/19/2009 | WO2009021740A2 Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 02/19/2009 | WO2009021622A1 Extracts with liver-x-receptor modulators, compounds and their use especially in weight control |
| 02/19/2009 | WO2009021293A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
| 02/19/2009 | WO2009000552A3 Compositions for the treatment of hyperphenylalaninemia |
| 02/19/2009 | WO2008149382A8 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application |
| 02/19/2009 | WO2008130630A3 Polymorphic form of rimonabant hydrochloride and processes for preparation thereof |
| 02/19/2009 | WO2008126756A9 Seleniferous compound and, containing the same, plant and nutritional supplement |
| 02/19/2009 | WO2008106128A3 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1 |
| 02/19/2009 | WO2008046083A3 Use of oxindole compounds as therapeutic agents |
| 02/19/2009 | WO2008042892A3 Fatty acid amide hydrolase inhibitors for energy metabolism disorders |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048340 Growth hormone secretion regulator |
| 02/19/2009 | US20090048338 Biologically active oils |
| 02/19/2009 | US20090048313 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048276 Inhibitors of Fatty Acid Synthase (Fas) |
| 02/19/2009 | US20090048275 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048258 Amide Compound |
| 02/19/2009 | US20090048257 Compounds that modulate ppar activity, their preparation and use |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048167 Disease treatment via antimicrobial peptides or their inhibitors |
| 02/19/2009 | US20090048152 Systems and Methods for Glycemic Control During Pump Disconnection |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047368 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage |
| 02/19/2009 | US20090047355 Process for producing pulverulent phytosterol formulations |
| 02/19/2009 | US20090047340 Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis |
| 02/19/2009 | US20090047304 Composition For Body Fat Reduction |
| 02/19/2009 | US20090047267 Process for the Preparation of A Non-Corrosive Base Solution And Methods Of Using Same |
| 02/19/2009 | US20090047266 Lipases for Pharmaceutical Use |
| 02/19/2009 | US20090047234 Compositions for nasal delivery |
| 02/19/2009 | US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby |
| 02/19/2009 | CA2697265A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 02/19/2009 | CA2696558A1 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative |
| 02/19/2009 | CA2696336A1 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2695955A1 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 02/19/2009 | CA2695878A1 5-membered heterocyclic compound |
| 02/19/2009 | CA2695088A1 Novel piperazine amide derivatives |
| 02/19/2009 | CA2694863A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity |
| 02/18/2009 | EP2025674A1 Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2025335A1 Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism |
| 02/18/2009 | EP2024364A1 Heterocyclic compounds as calcium channel blockers |
| 02/18/2009 | EP2024360A2 Substituted pyrazolopyrimidines |
| 02/18/2009 | EP2024347A1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 02/18/2009 | EP2024342A2 Substituted 2-amino-fused heterocyclic compounds |
| 02/18/2009 | EP2024340A1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2024339A1 4,5-diphenyl-pyrimidinyl-oxy or -mercapto substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2024338A1 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments |
| 02/18/2009 | EP2023955A2 Administration of anti-cd3 antibodies in the treatment of autoimmune diseases |
| 02/18/2009 | EP2023943A2 Methods for treating diabetes |
| 02/18/2009 | EP2023939A2 Compounds and methods for modulating expression of pcsk9 |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP2023902A1 Dpp iv inhibitor formulations |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 02/18/2009 | EP1513519B1 The use of substituted cyanopyrrolidines for treating hyperlipidemia |
| 02/18/2009 | EP1463563B1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP1021167B1 High and low load formulations of igf-i in multivesicular liposomes |
| 02/18/2009 | CN101370816A Crystalline form of 1¡ä-(1-methylethyl)- 4¡ä-[(2-fluoro-4-methoxyphenyl)methyl]-5¡ä-methyl-1h-pyrazol-3¡ä-o-beta-d-glucopyranoside, a method for its preparation and the use thereof for preparing medic |
| 02/18/2009 | CN101370796A Thiazoles as 11 beta-HSD1 inhibitors |
| 02/18/2009 | CN101370782A Alkylsulphonamide quinolines |
| 02/18/2009 | CN101370774A Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 02/18/2009 | CN101370555A Novel use of (-)-epigallocatechin gallate |
| 02/18/2009 | CN101370501A Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 02/18/2009 | CN101370396A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101367881A High-efficiency preparation method for glossy ganoderma polysaccharide |
| 02/18/2009 | CN101367873A Modified glucagon sample peptide-1analogue and modifying matter, and uses thereof |
| 02/18/2009 | CN101367861A 2-hydroxyl-3-deoxidized pentacyclic triterpenoid and derivant, preparation method and uses thereof |
| 02/18/2009 | CN101367851A Oligosaccharide derivative |
| 02/18/2009 | CN101367840A Phosphine isocoumarin amide, synthesis and uses thereof |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/18/2009 | CN101367787A Mango aglycone, preparation purification process and uses thereof |
| 02/18/2009 | CN101367745A Novel preparation process for nano-aminophenol complex compound |
| 02/18/2009 | CN101366943A Hemoglobin polypeptide aminophenol nutrient and preparation method thereof |
| 02/18/2009 | CN101366926A Chinese medicinal composition for treating deficiency of both qi and yin type diabetes |
| 02/18/2009 | CN101366918A Preparation method of medicinal granules for clearing fat, reducing blood pressure and pacifying the mind |
| 02/18/2009 | CN101366908A Traditional Chinese medicine for treating diabetes |
| 02/18/2009 | CN101366907A Lily green tea beauty treatment weight reducing particle |
| 02/18/2009 | CN101366884A Preparation technique for compound formulation for reducing blood fat and blood sugar |
| 02/18/2009 | CN101366883A Uses of panax ginseng gynostemma pentaphylla compound formulation in adjusting blood fat and blood sugar |
| 02/18/2009 | CN101366882A Compound formulation with function of reducing blood fat and blood sugar |